{"id":1500,"date":"2010-04-15T13:07:20","date_gmt":"2010-04-15T17:07:20","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/%e2%80%a2-prostate-cancer-and-endocrine-therapy-linked-to-increased-risk-of-thromboembolic-disease\/"},"modified":"2011-07-19T17:44:59","modified_gmt":"2011-07-19T21:44:59","slug":"prostate-cancer-and-endocrine-therapy-linked-to-increased-risk-of-thromboembolic-disease","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2010\/04\/15\/prostate-cancer-and-endocrine-therapy-linked-to-increased-risk-of-thromboembolic-disease\/","title":{"rendered":"Prostate Cancer and Endocrine Therapy Linked to Increased Risk of Thromboembolic Disease"},"content":{"rendered":"<p><strong>Prostate Cancer and Endocrine Therapy Linked to Increased Risk of Thromboembolic Disease:<\/strong> To assess the risk of thromboembolic disease in men with prostate cancer, Mieke Van Hemelrijck and colleagues analyzed data from the National Prostate Cancer Register in Sweden. They report, in <a href=\"http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045%2810%2970038-3\/abstract\">a paper published online in <em>Lancet Oncology<\/em><\/a>, that men with prostate cancer had an elevated risk of thromboembolic disease. The highest risk was observed in those patients receiving endocrine therapy. In <a href=\"http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045%2810%2970063-2\/fulltext\">an accompanying comment<\/a>, Phillip Saylor and Annemarie Fogerty conclude that &#8220;the data should increase clinical suspicion for venous thromboembolism in men with prostate cancer, and stimulate further study of the potential interactions between androgen deprivation and blood coagulation.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Prostate Cancer and Endocrine Therapy Linked to Increased Risk of Thromboembolic Disease: To assess the risk of thromboembolic disease in men with prostate cancer, Mieke Van Hemelrijck and colleagues analyzed data from the National Prostate Cancer Register in Sweden. They report, in a paper published online in Lancet Oncology, that men with prostate cancer had [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1500","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=1500"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1500\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=1500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=1500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=1500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}